Found: 115
Select item for more details and to access through your institution.
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 29, doi. 10.1093/jjco/hyy179
- By:
- Publication type:
- Article
Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.897991
- By:
- Publication type:
- Article
Overexpression of the base excision repair NTHL1 glycosylase causes genomic instability and early cellular hallmarks of cancer.
- Published in:
- Nucleic Acids Research, 2018, v. 46, n. 9, p. 4515, doi. 10.1093/nar/gky162
- By:
- Publication type:
- Article
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0
- By:
- Publication type:
- Article
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 371, doi. 10.1016/j.cllc.2020.11.004
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
- By:
- Publication type:
- Article
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pulmonary Sarcomatoid Carcinoma: of the National Cancer Data An Analysis Base.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 3, p. 286, doi. 10.1016/j.cllc.2016.11.016
- By:
- Publication type:
- Article
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variables.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The role of cetuximab in the management of non-small-cell lung cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The Role of Cetuximab in the Management of Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 4, p. 230, doi. 10.3816/CLC.2009.n.031
- By:
- Publication type:
- Article
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081162
- By:
- Publication type:
- Article
The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020899
- By:
- Publication type:
- Article
Lung Cancer in the Elderly: What's Age Got to Do With It?
- Published in:
- Oncology (08909091), 2010, v. 24, n. 12, p. 1120
- By:
- Publication type:
- Article
Preoperative Therapy for Early-Stage NSCLC: Opportunities and Challenges.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 10, p. 886
- By:
- Publication type:
- Article
Proof of Efficacy for Adjuvant Treatment in Stage lB NSCLC: Searching for a Needle in a Haystack?
- Published in:
- Oncology (08909091), 2008, v. 22, n. 5, p. 522
- By:
- Publication type:
- Article
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 112, doi. 10.3390/jcm12010112
- By:
- Publication type:
- Article
Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-11214-9
- By:
- Publication type:
- Article
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0254125
- By:
- Publication type:
- Article
Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 4, p. 882, doi. 10.1002/1878-0261.12645
- By:
- Publication type:
- Article
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-1012-4
- By:
- Publication type:
- Article
Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer.
- Published in:
- Advanced Science, 2024, v. 11, n. 35, p. 1, doi. 10.1002/advs.202310126
- By:
- Publication type:
- Article
Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7339, doi. 10.1002/cam4.5423
- By:
- Publication type:
- Article
Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 358, doi. 10.1002/cam4.4847
- By:
- Publication type:
- Article
Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7511, doi. 10.1002/cam4.3416
- By:
- Publication type:
- Article
Poly ( ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 6, p. 1579, doi. 10.1002/cam4.317
- By:
- Publication type:
- Article
What is the role of maintenance therapy in the treatment of non-small cell lung cancer?
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 4, p. 229, doi. 10.1177/1758834010368045
- By:
- Publication type:
- Article
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CheckMate 227: Nivolumab + Ipilimumab vs Platinum-Doublet Chemotherapy as First-Line Treatment for Advanced Non--Small Cell Lung Cancer (NSCLC) with High Tumor Mutational Burden (TMB).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2018, v. 9, p. 26
- By:
- Publication type:
- Article
Small-molecule Bax agonists for cancer therapy.
- Published in:
- Nature Communications, 2014, v. 5, n. 9, p. 4935, doi. 10.1038/ncomms5935
- By:
- Publication type:
- Article
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First‐Line Mutant Epidermal Growth Factor Receptor Non‐Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 349, doi. 10.1002/cpt.3113
- By:
- Publication type:
- Article
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 3, p. 743, doi. 10.1002/ijc.24759
- By:
- Publication type:
- Article
Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 487, doi. 10.1159/000514297
- By:
- Publication type:
- Article
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Spatially variant immune infiltration scoring in human cancer tissues.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00305-4
- By:
- Publication type:
- Article
Impact of Disease and Treatment Response in Drug–Drug Interaction Studies: Osimertinib and Simvastatin in Advanced Non‐Small Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 1, p. 41, doi. 10.1111/cts.12688
- By:
- Publication type:
- Article